Journal Article Page
European UrologyVolume 58, issue 2, pages e19-e28, August 2010
Case Study of the Month
Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma
Accepted 3 March 2010, Published online 12 March 2010, pages 307 - 310
Conflicts of interest
Joan Palou is a consultant for Sanofi-Pasteur, Lilly, and AMGEN. She receives company speaker honorariums from Sanofi-Pasteur and has participated in trials by Lilly and Zambon Group.
© 2010 European Association of Urology, Published by Elsevier B.V.
Recommend this article
Currently this article has a rating of 0. Please log in to recommend it.